資訊|論壇|病例

搜索

首頁 醫(yī)學(xué)論壇 專業(yè)文章 醫(yī)學(xué)進展 簽約作者 病例中心 快問診所 愛醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線題庫 醫(yī)學(xué)會議

您所在的位置:首頁 > 腫瘤科診療指南 > 2010ESMO胰腺癌臨床實踐指南

2010ESMO胰腺癌臨床實踐指南

2014-05-04 16:09 閱讀:1337 來源:愛愛醫(yī) 責(zé)任編輯:張子玲
[導(dǎo)讀] In Europe, cancer of the pancreas is the 10th most frequentcancer, accounting for some 2.6% of cancer in both sexes, andthe eighth leading cause of cancer-related death with 65 000deaths each year.

    《2010ESMO胰腺癌臨床實踐指南》內(nèi)容簡介:

   
In Europe, cancer of the pancreas is the 10th most frequentcancer, accounting for some 2.6% of cancer in both sexes, andthe eighth leading cause of cancer-related death with 65 000deaths each year.

    《2010ESMO胰腺癌臨床實踐指南》內(nèi)容預(yù)覽:

    
In men, the annual incidence rates rangebetween 8.7 (East) and 7.3 (North and West) per 100 000, andin women between 5.7 (North) and 4.5 (East)。 Men haveapproximately a half greater age-adjusted incidence rate thanwomen. Incidence increases steeply with age from 1.5 per100 000/year in patients 15–44 years of age to 55 per 100 000/year in patients >65 year of age. Pancreatic cancer is one of themost highly fatal cancers, with >95% of those affected dying oftheir disease. The high mortality rate is due to the highincidence of metastatic disease at diagnosis. No survivalincreases have been observed in the last years.

    點擊下載***:《2010ESMO胰腺癌臨床實踐指南》


分享到:
  版權(quán)聲明:

  本站所注明來源為"愛愛醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個人可與我們

  聯(lián)系zlzs@120.net,我們將立即進行刪除處理

意見反饋 關(guān)于我們 隱私保護 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved